Adipocytes and Obesity-Related Conditions Jointly Promote Breast Cancer Cell Growth and Motility: Associations With CAP1 for Prognosis
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Adipocytes and Obesity-Related Conditions Jointly Promote Breast Cancer Cell Growth and Motility: Associations With CAP1 for Prognosis
Authors
Keywords
-
Journal
Frontiers in Endocrinology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-11-22
DOI
10.3389/fendo.2018.00689
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Association of RETN and CAP1 SNPs, Expression and Serum Resistin Levels with Breast Cancer in Mexican Women
- (2018) Alejandrina Muñoz-Palomeque et al. Genetic Testing and Molecular Biomarkers
- Adipocytes induce distinct gene expression profiles in mammary tumor cells and enhance inflammatory signaling in invasive breast cancer cells
- (2018) Annina Nickel et al. Scientific Reports
- Association of Body Mass Index and Age With Subsequent Breast Cancer Risk in Premenopausal Women
- (2018) et al. JAMA Oncology
- TScratch: a novel and simple software tool for automated analysis of monolayer wound healing assays
- (2018) Tobias Gebäck et al. BIOTECHNIQUES
- Resistin facilitates breast cancer progression via TLR4-mediated induction of mesenchymal phenotypes and stemness properties
- (2017) C-H Wang et al. ONCOGENE
- Resistin promotes CCL4 expression through toll-like receptor-4 and activation of the p38-MAPK and NF-κB signaling pathways: implications for intervertebral disc degeneration
- (2017) Z. Li et al. OSTEOARTHRITIS AND CARTILAGE
- Interactions between Adipocytes and Breast Cancer Cells Stimulate Cytokine Production and Drive Src/Sox2/miR-302b–Mediated Malignant Progression
- (2016) Manuel Picon-Ruiz et al. CANCER RESEARCH
- Adipose microenvironment promotes triple negative breast cancer cell invasiveness and dissemination by producing CCL5
- (2016) Vittoria D'Esposito et al. Oncotarget
- Circulating resistin levels and obesity-related cancer risk: A meta-analysis
- (2016) Wei-Jing Gong et al. Oncotarget
- Resistin, a fat-derived secretory factor, promotes metastasis of MDA-MB-231 human breast cancer cells through ERM activation
- (2016) Jung Ok Lee et al. Scientific Reports
- CAP1 (Cyclase-Associated Protein 1) Exerts Distinct Functions in the Proliferation and Metastatic Potential of Breast Cancer Cells Mediated by ERK
- (2016) Haitao Zhang et al. Scientific Reports
- Resistin, Visfatin, Adiponectin, and Leptin: Risk of Breast Cancer in Pre- and Postmenopausal Saudi Females and Their Possible Diagnostic and Predictive Implications as Novel Biomarkers
- (2015) Adel M. A. Assiri et al. DISEASE MARKERS
- Circulating Adipokines and Inflammatory Markers and Postmenopausal Breast Cancer Risk
- (2015) Marc J. Gunter et al. JNCI-Journal of the National Cancer Institute
- Resistin and interleukin-6 exhibit racially-disparate expression in breast cancer patients, display molecular association and promote growth and aggressiveness of tumor cells through STAT3 activation
- (2015) Sachin K. Deshmukh et al. Oncotarget
- Circulating Adipokines and Inflammatory Markers and Postmenopausal Breast Cancer Risk
- (2015) Marc J. Gunter et al. JNCI-Journal of the National Cancer Institute
- Overweight, Obesity, and Postmenopausal Invasive Breast Cancer Risk
- (2015) Marian L. Neuhouser et al. JAMA Oncology
- Adenylyl Cyclase-Associated Protein 1 Is a Receptor for Human Resistin and Mediates Inflammatory Actions of Human Monocytes
- (2014) Sahmin Lee et al. Cell Metabolism
- Knocking down the expression of adenylate cyclase-associated protein 1 inhibits the proliferation and migration of breast cancer cells
- (2014) Xia-Fei Yu et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- High expression and prognostic role of CAP1 and CtBP2 in breast carcinoma: associated with E-cadherin and cell proliferation
- (2014) Xiancheng Liu et al. MEDICAL ONCOLOGY
- Metformin-mediated growth inhibition involves suppression of the IGF-I receptor signalling pathway in human pancreatic cancer cells
- (2013) Emelie Karnevi et al. BMC CANCER
- Expression and prognostic significance of fibronectin and matrix metalloproteases in breast cancer metastasis
- (2013) Belen Fernandez-Garcia et al. HISTOPATHOLOGY
- Celecoxib synergizes human pancreatic ductal adenocarcinoma cells to sorafenib-induced growth inhibition
- (2013) Ann H. Rosendahl et al. PANCREATOLOGY
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- (2013) J. Gao et al. Science Signaling
- Adipocyte-released insulin-like growth factor-1 is regulated by glucose and fatty acids and controls breast cancer cell growth in vitro
- (2012) V. D’Esposito et al. DIABETOLOGIA
- Resistin expression in breast cancer tissue as a marker of prognosis and hormone therapy stratification
- (2012) Yi-Chen Lee et al. GYNECOLOGIC ONCOLOGY
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- Cancer-Associated Adipocytes Exhibit an Activated Phenotype and Contribute to Breast Cancer Invasion
- (2011) B. Dirat et al. CANCER RESEARCH
- Targeting the Phosphoinositide-3 (PI3) Kinase Pathway in Breast Cancer
- (2011) J. Baselga ONCOLOGIST
- GOBO: Gene Expression-Based Outcome for Breast Cancer Online
- (2011) Markus Ringnér et al. PLoS One
- Human resistin: found in translation from mouse to man
- (2011) Daniel R. Schwartz et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Effect of Obesity on Prognosis After Early-Stage Breast Cancer
- (2010) Marianne Ewertz et al. JOURNAL OF CLINICAL ONCOLOGY
- Cross-Sectional Associations Bet ween Abdominal and Thoracic Adipose Tissue Compartments and Adiponectin and Resistin in the Framingham Heart Study
- (2009) S. H. Jain et al. DIABETES CARE
- Resistin competes with lipopolysaccharide for binding to toll-like receptor 4
- (2009) Andrej Tarkowski et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started